Connect to other sites within the UBM Medica Network
The American Association for Cancer Research presented data on Merkel cell carcinoma at their annual meeting in New Orleans. Image © jovan vitanovski/Shutterstock.com
Can a UV-Resistance Gene Predict Skin Cancer Risk?
The UV radiation resistance-associated tumor suppressor gene coordinates DNA repair and might predict skin cancer risk, according to research published in the journal Molecular Cell.
Protein May Identify Which Melanoma Patients Most Likely to Benefit From Immunotherapy
It now turns out that Bim, a downstream signaling molecule of the PD-1 pathway, may hold the clue to which patients may be successful on immunotherapy for metastatic melanoma.
Researchers Identify Specific Metabolic Pathway in Triple-Negative Breast Cancer
While metabolic pathways in breast cancer have been difficult to identify, researchers at the University of California Berkeley have discovered a new target in triple-negative breast cancer.
Growth Kinetics May Help Identify Ibrutinib Resistance in CLL Patients
Researchers at Weill Cornell Medicine recently published a study in Nature Communications explaining that the rate at which genetically mutated cancer cells grow may help explain why some CLL patients develop treatment resistance.
New Target Identified for Preventing Castration-Resistant Prostate Cancer
A new study published in Nature Communications is suggesting that castration-resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment.
FDA Approves Nivolumab for Relapsed Classical Hodgkin Lymphoma
The US Food and Drug Administration (FDA) granted accelerated approval of nivolumab (Opdivo) based on overall response rate (ORR) in classical Hodgkin lymphoma patients.
Might DHA Enhance Regorafenib’s Antitumor Effects in Kidney Cancer?
The fatty acid DHA, a component of fish oil, might enhance regorafenib’s ability to slow angiogenesis and tumor growth in renal cell carcinoma.
March 2016 News Recap
In case you missed it, check out our March recap featuring some of the latest in clinical trial news, a new indication for Afinitor, how genetics affect prognosis, and more.
Epidermal Growth Factor Receptor Inhibitor Cutaneous Side Effects
This slide show highlights some of the cutaneous side effects related to the use of epidermal growth factor receptor inhibitors (EGFRI).
Slide Show: Highlights From the 2015 ASCO Breast Cancer Symposium
This slide show highlights some of the presentations that took place at the 2015 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco, September 25-27, 2015.
Slide Show: Trends in Targeted Therapies and Immunotherapies
This slide show provides information on the present and future of targeted therapies and immunotherapies based on a report from the IMS Institute for Healthcare Informatics.
By clicking Accept, you agree to become a member of the UBM Medica Community.